Advanced search
Publication Cover
OncoImmunology Volume 9, 2020 - Issue 1
Submit an article Journal homepage
3,563
Views
32
CrossRef citations to date
0
Altmetric
Original Research

Converging focal radiation and immunotherapy in a preclinical model of triple negative breast cancer: contribution of VISTA blockade

Karsten A. Pilonesa Department of Radiation Oncology, Weill Cornell Medical College, New York, NY, USAORCID Iconhttps://orcid.org/0000-0002-0982-3260View further author information
ORCID Icon,
Michal Henslerb Sotio, Prague, Czech RepublicORCID Iconhttps://orcid.org/0000-0002-8767-0722View further author information
ORCID Icon,
Camille Daviauda Department of Radiation Oncology, Weill Cornell Medical College, New York, NY, USAView further author information
,
Jeffrey Kraynaka Department of Radiation Oncology, Weill Cornell Medical College, New York, NY, USAView further author information
,
Jitka Fucikovab Sotio, Prague, Czech Republic;c Department of Immunology, Charles University, 2 Faculty of Medicine and University Hospital Motol, Prague, Czech RepublicView further author information
,
Lorenzo Galluzzia Department of Radiation Oncology, Weill Cornell Medical College, New York, NY, USA;d Sandra and Edward Meyer Cancer Center, New York, NY, USA;e Caryl and Isreal Englander Institute for Precision Medicine, Weill Cornell Medical College, New York, NY, USAView further author information
,
Sandra Demariaa Department of Radiation Oncology, Weill Cornell Medical College, New York, NY, USA;d Sandra and Edward Meyer Cancer Center, New York, NY, USA;f Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, New York, NY, USAORCID Iconhttps://orcid.org/0000-0003-4426-0499View further author information
ORCID Icon &
Silvia C. Formentia Department of Radiation Oncology, Weill Cornell Medical College, New York, NY, USA;d Sandra and Edward Meyer Cancer Center, New York, NY, USACorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-8227-8924View further author information
ORCID Icon show all
Article: 1830524 | Received 19 Aug 2020, Accepted 25 Sep 2020, Published online: 20 Oct 2020

Citations (32)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (6)

Rui Zhang, Samantha D Clark, Beibei Guo, Tianyi Zhang, Duane Jeansonne, Samithamby J Jeyaseelan, Joseph Francis & Weishan Huang. (2023) Challenges in the combination of radiotherapy and immunotherapy for breast cancer. Expert Review of Anticancer Therapy 23:4, pages 375-383.
Read now
Lucillia Bezu, Oliver Kepp & Guido Kroemer. (2022) Immunogenic stress induced by local anesthetics injected into neoplastic lesions. OncoImmunology 11:1.
Read now
Marco Tagliamento, Elisa Agostinetto, Roberto Borea, Mariana Brandão, Francesca Poggio, Alfredo Addeo & Matteo Lambertini. (2021) VISTA: A Promising Target for Cancer Immunotherapy?. ImmunoTargets and Therapy 10, pages 185-200.
Read now
Guido Kroemer & Oliver Kepp. (2021) Small cell lung cancer responds to immunogenic chemotherapy followed by PD-1 blockade. OncoImmunology 10:1.
Read now
Juliette Humeau, Julie Le Naour, Lorenzo Galluzzi, Guido Kroemer & Jonathan G. Pol. (2021) Trial watch: intratumoral immunotherapy. OncoImmunology 10:1.
Read now
Takahiro Yamazaki, Erik Wennerberg, Michal Hensler, Aitziber Buqué, Jeffrey Kraynak, Jitka Fucikova, Xi Kathy Zhou, Baldur Sveinbjørnsson, Øystein Rekdal, Sandra Demaria & Lorenzo Galluzzi. (2021) LTX-315-enabled, radiotherapy-boosted immunotherapeutic control of breast cancer by NK cells. OncoImmunology 10:1.
Read now

Articles from other publishers (26)

Siyu Li, Geng Wang, Yan Ren, Xinyue Liu, Yixuan Wang, Jianing Li, Hua Liu, Jiaqiang Yang, Jingjun Xing, Yanru Zhang, Canxia He, Suling Xu, Xin Hou & Na Li. (2024) Expression and function of VISTA on myeloid cells. Biochemical Pharmacology 222, pages 116100.
Crossref
Sawsan Sudqi Said & Wisam Nabeel Ibrahim. (2024) Breaking Barriers: The Promise and Challenges of Immune Checkpoint Inhibitors in Triple-Negative Breast Cancer. Biomedicines 12:2, pages 369.
Crossref
Teresa Irianto, Udo S. Gaipl & Michael Rückert. 2024. Immune Checkpoint Biology in Health and Disease. Immune Checkpoint Biology in Health and Disease 239 277 .
Guanglei Chen, Xi Gu, Jinqi Xue, Xu Zhang, Xiaopeng Yu, Yu Zhang, Ailin Li, Yi Zhao, Guijin He, Meiyue Tang, Fei Xing, Jianqiao Yin, Xiaobo Bian, Ye Han, Shuo Cao, Chao Liu, Xiaofan Jiang, Keliang Zhang, Yan Xia, Huajun Li, Nan Niu & Caigang Liu. (2023) Effects of neoadjuvant stereotactic body radiotherapy plus adebrelimab and chemotherapy for triple-negative breast cancer: A pilot study. eLife 12.
Crossref
Yuli Wang, Tao Yue & Qingqing He. (2023) Comprehensive analysis of ICD-related lncRNAs in predicting risk stratification, clinical prognosis and immune response for breast cancer. Aging 15:17, pages 8833-8850.
Crossref
Görkem Yazıcı Şener, Osman Sütcüoğlu, Betül Öğüt, Deniz Can Güven, Altan Kavuncuoğlu, Nuriye Özdemir, Ahmet Özet, Sercan Aksoy, Yeşim Gaye Güler Tezel, Nalan Akyürek & Ozan Yazıcı. (2023) Comparison of PD-L1 and VISTA expression status in primary and recurrent/refractory tissue after (chemo)radiotherapy in head and neck cancer. Strahlentherapie und Onkologie 199:8, pages 761-772.
Crossref
Haoyu Liu, Zhicheng Wang, Yuntao Zhou & Yanming Yang. (2023) MDSCs in breast cancer: an important enabler of tumor progression and an emerging therapeutic target. Frontiers in Immunology 14.
Crossref
Alexander Chi & Nam Phong Nguyen. (2023) Mechanistic rationales for combining immunotherapy with radiotherapy. Frontiers in Immunology 14.
Crossref
Paulina Chmiel, Katarzyna Gęca, Adam Michalski, Martyna Kłosińska, Agnieszka Kaczyńska, Wojciech P. Polkowski, Zuzanna Pelc & Magdalena Skórzewska. (2023) Vista of the Future: Novel Immunotherapy Based on the Human V-Set Immunoregulatory Receptor for Digestive System Tumors. International Journal of Molecular Sciences 24:12, pages 9945.
Crossref
Mei Zhu, Xi Yang, Jia You, Lingnan Zheng, Cheng Yi & Ying Huang. (2023) Nanobiotechnology‐mediated radioimmunotherapy treatment for triple‐negative breast cancer. MedComm – Biomaterials and Applications 2:1.
Crossref
Maria Manuela Rosado & Claudio Pioli. (2023) Radiotherapy, PARP Inhibition, and Immune-Checkpoint Blockade: A Triad to Overcome the Double-Edged Effects of Each Single Player. Cancers 15:4, pages 1093.
Crossref
Carlos Jiménez-Cortegana & Lorenzo Galluzzi. 2023. Myeloid-derived suppressor cells. Myeloid-derived suppressor cells xiii xix .
Caroline P. Kerr, Joseph J. Grudzinski, Thanh Phuong Nguyen, Reinier Hernandez, Jamey P. Weichert & Zachary S. Morris. (2022) Developments in Combining Targeted Radionuclide Therapies and Immunotherapies for Cancer Treatment. Pharmaceutics 15:1, pages 128.
Crossref
Xi-Yang Tang, Yan-Lu Xiong, Xian-Gui Shi, Ya-Bo Zhao, An-Ping Shi, Kai-Fu Zheng, Yu-Jian Liu, Tao Jiang, Nan Ma & Jin-Bo Zhao. (2022) IGSF11 and VISTA: a pair of promising immune checkpoints in tumor immunotherapy. Biomarker Research 10:1.
Crossref
Alcida Karz, Maya Dimitrova, Kevin Kleffman, Christopher Alvarez‐Breckenridge, Michael B. Atkins, Adrienne Boire, Marcus Bosenberg, Priscilla Brastianos, Daniel P. Cahill, Qing Chen, Sherise Ferguson, Peter Forsyth, Isabella C. Glitza Oliva, Sarah B. Goldberg, Sheri L. Holmen, Jonathan P. S. Knisely, Glenn Merlino, Don X. Nguyen, Michael E. Pacold, Eva Perez‐Guijarro, Keiran S. M. Smalley, Hussein A. Tawbi, Patrick Y. Wen, Michael A. Davies, Harriet M. Kluger, Janice M. Mehnert & Eva Hernando. (2022) Melanoma central nervous system metastases: An update to approaches, challenges, and opportunities. Pigment Cell & Melanoma Research 35:6, pages 554-572.
Crossref
Trevor S. Anderson, Amanda L. Wooster, Savanna L. Piersall, Izuchukwu F. Okpalanwaka & Devin B. Lowe. (2022) Disrupting cancer angiogenesis and immune checkpoint networks for improved tumor immunity. Seminars in Cancer Biology 86, pages 981-996.
Crossref
Sven Mostböck, Helen Haixia Wu, Timothy Fenn, Bettina Riegler, Susanne Strahlhofer, Yining Huang, Gale Hansen, Rachel Kroe-Barrett, Iñigo Tirapu & Anne B. Vogt. (2022) Distinct immune stimulatory effects of anti-human VISTA antibodies are determined by Fc-receptor interaction. Frontiers in Immunology 13.
Crossref
Carlos Jiménez-Cortegana, Claudia Galassi, Vanessa Klapp, Dmitry I. Gabrilovich & Lorenzo Galluzzi. (2022) Myeloid-Derived Suppressor Cells and Radiotherapy. Cancer Immunology Research 10:5, pages 545-557.
Crossref
Ming Xu, Jin-hua Lu, Ya-zhen Zhong, Jing Jiang, Yue-zhong Shen, Jing-yang Su & Sheng-you Lin. (2022) Immunogenic Cell Death-Relevant Damage-Associated Molecular Patterns and Sensing Receptors in Triple-Negative Breast Cancer Molecular Subtypes and Implications for Immunotherapy. Frontiers in Oncology 12.
Crossref
Siting Yu, Yang Wang, Ping He, Bianfei Shao, Fang Liu, Zhongzheng Xiang, Tian Yang, Yuanyuan Zeng, Tao He, Jiachun Ma, Xiran Wang & Lei Liu. (2022) Effective Combinations of Immunotherapy and Radiotherapy for Cancer Treatment. Frontiers in Oncology 12.
Crossref
Carlos Jiménez-Cortegana, Claudia Galassi & Lorenzo Galluzzi. (2022) MDSCs sneak CSCs out of (immuno)surveillance. Trends in Immunology 43:1, pages 1-3.
Crossref
Claudia Galassi, Yangjingyi Ruan, Ai Sato, Carlos Jiménez-Cortegana, Vanessa Klapp, Norma Bloy, Emma Guilbaud, Giulia Petroni, Aitziber Buqué, Lorenzo Galluzzi & Takahiro Yamazaki. 2022. Radiation Oncology and Radiotherapy Part A. Radiation Oncology and Radiotherapy Part A 145 161 .
Carlos Jiménez-Cortegana, Vanessa Klapp, Norma Bloy, Claudia Galassi, Ai Sato, Takahiro Yamazaki, Aitziber Buqué, Lorenzo Galluzzi & Giulia Petroni. 2022. Radiation Oncology and Radiotherapy Part A. Radiation Oncology and Radiotherapy Part A 1 16 .
Zhijie Xu, Bi Peng, Qiuju Liang, Xi Chen, Yuan Cai, Shuangshuang Zeng, Kewa Gao, Xiang Wang, Qiaoli Yi, Zhicheng Gong & Yuanliang Yan. (2021) Construction of a Ferroptosis-Related Nine-lncRNA Signature for Predicting Prognosis and Immune Response in Hepatocellular Carcinoma. Frontiers in Immunology 12.
Crossref
Negar Hosseinkhani, Afshin Derakhshani, Mahdi Abdoli Shadbad, Antonella Argentiero, Vito Racanelli, Tohid Kazemi, Ahad Mokhtarzadeh, Oronzo Brunetti, Nicola Silvestris & Behzad Baradaran. (2021) The Role of V-Domain Ig Suppressor of T Cell Activation (VISTA) in Cancer Therapy: Lessons Learned and the Road Ahead. Frontiers in Immunology 12.
Crossref
Giulia Petroni, Aitziber Buqué, Takahiro Yamazaki, Norma Bloy, Maurizio Di Liberto, Selina Chen-Kiang, Silvia C. Formenti & Lorenzo Galluzzi. (2021) Radiotherapy Delivered before CDK4/6 Inhibitors Mediates Superior Therapeutic Effects in ER+ Breast Cancer. Clinical Cancer Research 27:7, pages 1855-1863.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.